Vaccine News and Research

Latest Vaccine News and Research

Lack of access to information for health workers in resource-poor settings is a major obstacle to achieving the 2015 millennium goals for global health

A Public Health article published online today (9 July 2004) highlights how a lack of access to health information for health workers in resource-poor settings is a major obstacle to achieving the 2015 millennium goals for global health.

12 Jul 2004

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly using a new laboratory technique developed by an international research team collaborating with the National Institute of Allergy and Infectious Diseases (NIAID).

12 Jul 2004

New rotavirus vaccines could reduce mortality from the disease by up to 60 percent

Health officials from 16 countries today asked for budgetary support "to ensure the sustainability of the existing vaccination programs and the introduction of new vaccines," at the conclusion of a global symposium on rotavirus, a diarrheal disease that kills over 600,000 children worldwide every year.

10 Jul 2004

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics has announced that it has been awarded a five-year, $14.2 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

10 Jul 2004

Recent tuberculosis research holds promise for developing a more effective vaccine

Tuberculosis, a mycobacterium that infects human lungs, still claims the lives of about 2 million people every year. Existing vaccines provide questionable protection, and they can even cause disease in individuals with compromised immune systems.

9 Jul 2004

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Emerging infectious diseases, which have shaped the course of humanity and caused incalculable suffering and death, will continue to confront society in unpredictable ways as long as humans and microbes co-exist

9 Jul 2004

Environmental risks in the development of autism and autism spectrum disorders

Funding for a new study to find out more about the role of environmental risks in the development of autism and autism spectrum disorders (ASD), has been announced by the Medical Research Council (MRC).

8 Jul 2004

Researchers found that a significant number of men get the hepatitis B virus behind bars

In the first study to gauge the risks of contracting HIV and hepatitis in Rhode Island prisons, Brown University researchers found that a significant number of men get the hepatitis B virus behind bars – a finding that led the team to call for prison-wide vaccinations. Results are published in the current edition of the American Journal of Public Health.

7 Jul 2004

Research could help disarm deadly retroviruses such as HIV or SARS

Taken to its ultimate outcome, the research that biology professor Dr. Steve Howard is working on could help disarm deadly retroviruses such as HIV or SARS.

7 Jul 2004

Chiron has received a license for its new meningococcal B vaccine for New Zealand

Chiron developed the vaccine, in close collaboration with the New Zealand Ministry of Health and the Norwegian Institute of Public Health, to protect against the specific meningococcal B strain responsible for a 13-year epidemic in the country.

7 Jul 2004

The impact of rotavirus on the world’s children

With vaccines against the killer disease of rotavirus almost in hand, government representatives, scientists, public health professionals and vaccine industry representatives will be convened in Mexico City to review progress toward safe, effective rotavirus vaccines and address the question of how to make sure they get to the world’s poorest children

7 Jul 2004

Extension of vaccination programs against anthrax to include U.S. forces in the Pacific Commands including Korea

William Winkenwerder, Jr., MD, assistant secretary of defense for health affairs has announced the extension of the vaccination programs against anthrax to include U.S. forces in the Pacific Commands including Korea.

4 Jul 2004

Reports of a serious polio outbreak among children in Rogo, Nigeria

Reports of a serious polio outbreak among children in Rogo, Kano State, have emerged. Kano is Nigeria's most populous northern state.

2 Jul 2004

Pneumococcal vaccination now free in Ontario

The pneumococcal vaccination, the first of three new free child vaccines being introduced by the McGuinty government, is now available, Health and Long-Term Care Minister George Smitherman announced today.

2 Jul 2004

Fall in the number of confirmed cases of Haemophilus influenzae type b (Hib) disease

A Health Protection Agency study has shown a sharp fall in the number of confirmed cases of Haemophilus influenzae type b (Hib) disease following the introduction of a Department of Health booster campaign, the Agency’s Board heard today.

2 Jul 2004

ASU and Mayo Clinic collaborate on a new joint nursing program

ASU and Mayo Clinic have reached an agreement to collaborate on a new joint nursing program based at Mayo Clinic Hospital in northeast Phoenix.

2 Jul 2004

Nigeria resuming polio immunization

The World Health Organization (WHO) has been informed by the Governor of Kano, Nigeria, of the intention to resume polio immunization campaigns there in early July.

30 Jun 2004

Harmless form of the herpes virus may help create a vaccine for Alzheimer’s disease

Scientists have taken an important step toward creating a vaccine against Alzheimer’s disease, customizing the response of the immune system with unprecedented precision.

30 Jun 2004

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

Oxford University's Therapeutic Antibody Centre (TAC) has received a Manufacturer's Authorisation (Investigational Medicinal Products) from the Medicines and Healthcare Products Regulatory Agency (MHRA).

29 Jun 2004

New £18M Medical Research Council facility

A new £18M Medical Research Council (MRC) facility to understand and compare the genetics of disease in mice and humans will be opened today, Wednesday 30 June, by Lord Sainsbury, Minister for Science and Technology.

29 Jun 2004

Vaccine News and Research

Latest Vaccine News and Research

Lack of access to information for health workers in resource-poor settings is a major obstacle to achieving the 2015 millennium goals for global health

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

New rotavirus vaccines could reduce mortality from the disease by up to 60 percent

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Recent tuberculosis research holds promise for developing a more effective vaccine

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Environmental risks in the development of autism and autism spectrum disorders

Researchers found that a significant number of men get the hepatitis B virus behind bars

Research could help disarm deadly retroviruses such as HIV or SARS

Chiron has received a license for its new meningococcal B vaccine for New Zealand

The impact of rotavirus on the world’s children

Extension of vaccination programs against anthrax to include U.S. forces in the Pacific Commands including Korea

Reports of a serious polio outbreak among children in Rogo, Nigeria

Pneumococcal vaccination now free in Ontario

Fall in the number of confirmed cases of Haemophilus influenzae type b (Hib) disease

ASU and Mayo Clinic collaborate on a new joint nursing program

Nigeria resuming polio immunization

Harmless form of the herpes virus may help create a vaccine for Alzheimer’s disease

Oxford Therapeutic Antibody Centre receives Manufacturer’s Authorisation

New £18M Medical Research Council facility

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Vaccine News and Research

Latest Vaccine News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in